In a head-to-head comparative study looking at weight loss, average weight loss was 50.3 lbs (22.9 kg) with tirzepatide compared to 33.1 lbs with semaglutide
There is no known cure for the condition, though withdrawal of the medication may lessen symptoms
Review of liver injury associated with dietary supplements
People come to the medication focused on weight loss, but many end up most excited about finally getting quality rest
During mealtime, the network presented in this study driven by OB GLP-1R may contribute to a decrease in SNS activity, and thus participate in the increase of glucose-induced insulin secretion, in concert with systemic GLP-1 and the GLP-1 dependent neuronal circuitry of the brainstem and hypothalamus recruited under normal physiological circumstances
None of the compounds described is approved for human self-administration outside of properly regulated clinical trials